Skip to content
Search

Latest Stories

DHSC issues five more SSPs for Pen V

The Department of Health and Social Care (DHSC) has issued a further five new Serious Shortage Protocols (SSPs) for Phenoxymethylpenicillin (Pen V) to enable the continued supply of antibiotics to patients.

“The new SSPs, introduced with immediate effect, allow community pharmacists to consider different oral antibiotic preparations, to enable the continued supply of antibiotics to patients and mitigate the ongoing supply disruptions affecting Phenoxymethylpenicillin,” said DHSC.


On Friday (16 December) SSP043-SSP047 has been authorised by the Secretary of State to provide pharmacists with procedures to follow in providing suitable alternative oral antibiotics to substitute Phenoxymethylpenicillin.

“For each SSP, DHSC has included specific patient counselling points which must be taken into account when deciding whether supply in accordance with an SSP is suitable for a patient.”

It has also urged the pharmacists to consider if a suitable supply can be made by using an alternative formulation of Phenoxymethylpenicillin following relevant SSP, before supplying an alternative antibiotic. DHSC added: “Where that is not possible only specified antibiotics can be substituted for prescriptions for a duration of no longer than 10 days, in order of preference depending on availability and the dosing needs for the patient.”

All current oral antibiotic SSPs

SSPSSP endorsement guidanceSSP Expiry
SSP040 Phenoxymethylpenicillin 125mg/5ml oral solution sugar free (issued 15/12/2022)SSP040 guide31 January 2023
SSP041 Phenoxymethylpenicillin 250mg/5ml oral solution sugar free (issued 15/12/2022)SSP041 guide31 January 2023
SSP042 Phenoxymethylpenicillin 250mg/5ml oral solution (issued 15/12/2022)SSP042 guide31 January 2023
SSP043 Phenoxymethylpenicillin 125mg/5ml oral solution (issued 16/12/2022)SSP043 guide31 January 2023
SSP044 Phenoxymethylpenicillin 125mg/5ml oral solution sugar free (issued 16/12/2022)SSP044 guide31 January 2023
SSP045 Phenoxymethylpenicillin 250mg/5ml oral solution (issued 16/12/2022)SSP045 guide31 January 2023
SSP046 Phenoxymethylpenicillin 250mg/5ml oral solution sugar free (issued 16/12/2022)SSP046 guide31 January 2023
SSP047 Phenoxymethylpenicillin 250mg tablets (issued 16/12/2022)SSP047 guide31 January 2023

In response to the issuing of SSPs, Gordon Hockey, PSNC’s Director, Legal, said yesterday:

“We asked DHSC to introduce Serious Shortage Protocols (SSPs) to help mitigate the ongoing supply disruption affecting the availability of phenoxymethylpenicillin (Pen V) and are pleased to see that some have now been introduced. However, PSNC was not involved in the development of these protocols and our team is urgently clarifying some points to provide contractors with additional guidance and to seek assurances around the reimbursement of any alternatives supplied. We will issue our additional guidance as soon as possible.

More widely, PSNC has also been pressing DHSC to think broadly about what other measures could help to manage the current situation and consider the introduction of greater flexibilities, such as allowing pharmacists more professional discretion to amend prescriptions separate to SSPs.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less